Merit Medical (MMSI) has disclosed a new risk, in the Corporate Activity and Growth category.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Merit Medical faces a potential business risk as none of its directors or officers reported any adoption or termination of trading arrangements under Rule 10b5-1 or non-Rule 10b5-1 during the quarter ending September 30, 2025. This lack of disclosure could signal a gap in transparency or strategic planning regarding insider trading activities, which might affect investor confidence. The absence of such arrangements might also indicate a missed opportunity for the company to manage insider transactions in a structured manner. Consequently, stakeholders may view this as a risk factor that could impact the company’s governance and market perception.
Overall, Wall Street has a Strong Buy consensus rating on MMSI stock based on 4 Buys and 1 Hold.
To learn more about Merit Medical’s risk factors, click here.